Transcriptional regulation of granulocyte and monocyte development

被引:254
作者
Friedman, AD [1 ]
机构
[1] Johns Hopkins Univ, Div Pediat Oncol, Baltimore, MD 21231 USA
关键词
granulocyte; monocyte; differentiation; C/EBP; PU.1;
D O I
10.1038/sj.onc.1205324
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Granulocytes and monocytes develop from a common myeloid progenitor. Early granulopoiesis requires the C/ EBPalpha, PU.1, RAR, CBF, and c-Myb transcription factors, and terminal neutrophil differentiation is dependent upon C/EBPepsilon, PU.1, Sp1, CDP, and HoxA10. Monopoiesis can be induced by Maf-B, c-Jun, or Egr-1 and is dependent upon PU.1, Sp1, and ICSBP. Signals eminating from cytokine receptors modulate factor activities but do not determine cell fates. Orchestration of the myeloid developmental program is achieved via cooperative gene regulation, via synergistic and inhibitory protein-protein interactions, via promoter auto-regulation and cross-regulation, via regulation of factor levels, and via induction of cell cycle arrest: For example, c-Myb and C/EBPalpha cooperate to activate the mim-1 and NE promoters, PU.1, C/EBPalpha,, and CBF, regulate the NE, MPO, and M-CSF Receptor genes. PU.1:GATA-1 interaction and C/EBP suppression of FOG transcription inhibits erythroid and megakaryocyte gene expression. c-Jun:PU.1, ICSBP:PU.1, and perhaps Maf:Jun complexes induce monocytic genes. PU.1 and C/EBPa activate their own promoters, C/EBPalpha rapidly induces PU.1 and C/EBPepsilon RNA expression, and RARalpha activates the C/ EBPepsilon promoter. Higher levels of PU.1 are required for monopoiesis than for B-lymphopoiesis, and higher C/ EBP levels may favor granulopoiesis over monopoiesis. CBF and c-Myb stimulate proliferation whereas C/EBPa induces a G1/S arrest; cell cycle arrest is required for terminal myelopoiesis, perhaps due to expression of p53 or hypo-phosphorylated Rb.
引用
收藏
页码:3377 / 3390
页数:14
相关论文
共 234 条
  • [1] AHNE B, 1994, J BIOL CHEM, V269, P17794
  • [2] A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
    Akashi, K
    Traver, D
    Miyamoto, T
    Weissman, IL
    [J]. NATURE, 2000, 404 (6774) : 193 - 197
  • [3] PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation
    Anderson, KL
    Smith, KA
    Perkin, H
    Hermanson, G
    Anderson, CG
    Jolly, DJ
    Maki, RA
    Torbett, BE
    [J]. BLOOD, 1999, 94 (07) : 2310 - 2318
  • [4] THE UBIQUITOUS SUBUNIT OF ERYTHROID TRANSCRIPTION FACTOR NF-E2 IS A SMALL BASIC-LEUCINE ZIPPER PROTEIN RELATED TO THE V-MAF ONCOGENE
    ANDREWS, NC
    KOTKOW, KJ
    NEY, PA
    ERDJUMENTBROMAGE, H
    TEMPST, P
    ORKIN, SH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) : 11488 - 11492
  • [5] A novel human CCAAT/enhancer binding protein gene, C/EBP epsilon, is expressed in cells of lymphoid and myeloid lineages and is localized on chromosome 14q11.2 close to the T-cell receptor alpha/delta locus
    Antonson, P
    Stellan, B
    Yamanaka, R
    Xanthopoulos, KG
    [J]. GENOMICS, 1996, 35 (01) : 30 - 38
  • [6] ACTIVATION OF CAMP AND MITOGEN RESPONSIVE GENES RELIES ON A COMMON NUCLEAR FACTOR
    ARIAS, J
    ALBERTS, AS
    BRINDLE, P
    CLARET, FX
    SMEAL, T
    KARIN, M
    FERAMISCO, J
    MONTMINY, M
    [J]. NATURE, 1994, 370 (6486) : 226 - 229
  • [7] BAE SC, 1993, ONCOGENE, V8, P809
  • [8] MUTUALLY EXCLUSIVE INTERACTION OF THE CCAAT-BINDING FACTOR AND OF A DISPLACEMENT PROTEIN WITH OVERLAPPING SEQUENCES OF A HISTONE GENE PROMOTER
    BARBERIS, A
    SUPERTIFURGA, G
    BUSSLINGER, M
    [J]. CELL, 1987, 50 (03) : 347 - 359
  • [9] A DIRECT PHYSICAL ASSOCIATION BETWEEN ETS AND AP-1 TRANSCRIPTION FACTORS IN NORMAL HUMAN T-CELLS
    BASSUK, AG
    LEIDEN, JM
    [J]. IMMUNITY, 1995, 3 (02) : 223 - 237
  • [10] ANTISENSE OLIGONUCLEOTIDES FROM THE STAGE-SPECIFIC MYELOID ZINC FINGER GENE MZF-1 INHIBIT GRANULOPOIESIS INVITRO
    BAVISOTTO, L
    KAUSHANSKY, K
    LIN, N
    HROMAS, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (05) : 1097 - 1101